缅北禁地

I studied in the field of Biology at the University of Bremen in Germany and finished my Bachelor of Science by publishing my thesis on the apoptotic effects of a synthetic cannabinoid on human cancer cell lines. Afterwards, I completed my Master of Science in the field of Neurosciences with distinction at the University of Bremen. I conducted an internship at the Monash University, Melbourne, Australia, where I investigated the effects of stress on a mouse breast cancer model. In my Masters project that I conducted at the Otto-von-Guericke-University Magdeburg, Germany, I focussed on the characterisation of Piezo1 modifiers in primary neurons.

I then joined the Trost laboratory at 缅北禁地 in September 2020 to conduct my PhD in the field of drug discovery and mass spectrometry. I was focussed on leveraging high-throughput mass spectrometry technology to enhance drug discovery in immunology. In collaboration with my industrial partner GlaxoSmithKline, we published a MALDI-TOF mass spectrometry-based screening workflow for the aminopeptidase ERAP1, and develop an assay for human immune cell characterisation using state of the art mass spectrometry.

I am now working in the Trost laboratory as a postdoctoral researcher, aiming to further develop MALDI-TOF MS based screening methods and LC-MS based proteomics methods for drug discovery.